Review Article
Therapeutic Options for the Management of the Cardiorenal Syndrome
Table 2
Pharmacokinetics of loop diuretics according to the renal function in heart failure patients. IV: intravenous; CrCl: Creatinine Clearance.
| | Moderate renal insufficiency | Severe renal insufficiency | | | Heart failure | | |
| | Maximal intravenous dose (mg) | IV Loading dose (mg) | Infusion rate (mg/hr) | Diuretic | | | | | CrCl <25 ml/min | CrCl 25–75 ml/min | CrCl >75 ml/min |
| Furosemide | 80–160 | 160–200 | 40–80 | 40 | 20 then 40 | 10 then 20 | 10 | Bumetanide | 4–8 | 8–10 | 1–2 | 1 | 1 then 2 | 0.5 then 1 | 0.5 | Torsemide | 20–50 | 50–100 | 10–20 | 20 | 10 then 20 | 5 then 10 | 5 |
|
|